Here are six facts:
1. Analysts gave the stock an $86.00 price target, revealing a 16.20 upside to the last closing price.
2. Wall Street sell-side analysts granted Medtronic a target price of $86.75.
3. Medtronic is projected to report earnings per share of $1.02 for the current fiscal quarter.
4. Medtronic last reported earnings of $1.16 for the period ending on April 30.
5. Sell-side analysts have a consensus mean earnings per share estimate of $4.39 for the current year.
6. The high end estimate of this year is $4.58 with the low being $4.19.
More articles on devices:
Intelligent Implant Systems closes funding round for spine system: 5 observations
Grand jury indicts troubled Texas spine surgeon — 5 key notes
Safe Orthopaedics SteriSpine proven effective: 5 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
